3 Stocks That Could Trounce the Market in 2025

If you're content with market-level returns, investing in an exchange-traded fund (ETF) is the way to go. But if not, you'll need to find stocks that hold the potential to pack more punch.Three Fool.com contributors believe they've identified just such stocks in the healthcare sector. Here's why they think Eli Lilly (NYSE: LLY), Summit Therapeutics (NASDAQ: SMMT), and Vertex Pharmaceuticals (NASDAQ: VRTX) could trounce the market in 2025.David Jagielski (Eli Lilly): For years, Eli Lilly has been a fairly safe bet to outperform the market. Last year, the pharma stock rose by more than 32%, generating better returns than the S&P 500's gains of 23%. And over a five-year stretch, the delta is even more significant, with Eli Lilly's stock climbing nearly 500% while the broad index has risen by 82%. Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool